The establishment of a combined serum-free and serum-supplemented culture method of obtaining functional cord blood-derived human mast cells

被引:39
作者
Dahl, C
Saito, H
Nielsen, HV
Schiotz, PO
机构
[1] Aarhus Univ Hosp, A Res, Dept Pediat, DK-8200 Aarhus C, Denmark
[2] Natl Childrens Med Res Ctr, Dept Allergy & Immunol, Tokyo 1548509, Japan
关键词
human mast cells; serum-free culture method; Fc epsilon RI; CD117; tryptase; chymase;
D O I
10.1016/S0022-1759(02)00011-X
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Serum-ftee cultures supplemented with stem cell factor (SCF) and IL-6 is reported to support the extensive growth of less functional human cord blood-derived mast cells. Objective: To obtain more functional mast cells from cord blood, we developed a culture system combining a serum-free condition for 0-8 weeks of culture, and followed by a serum-supplemented culture condition and examined the function of the cells compared to the cells cultured continuously in serum-free condition. Methods: Human cord blood progenitors Were purified With anti-CD133 antibody. They Were Cultured in a serum-free medium StemSpan Supplemented with SCF at 100 ng/ml and IL-6 at 50 ng/ml for 8 Weeks. Then, an aliquot of the cultured cells were cultured in the above condition but further Supplemented with 10% fetal calf serum (FCS). Results : The addition of FCS after 8 weeks of culture significantly increased the amount of histamine per mast cell (3.8 pg/cell) When compared to the serum-free condition (0.7 pg/cell). The cells cultured with FCS after 8 weeks expressed more FcepsilonRIalpha and released >30% of the histamine content upon anti-IgE stimulation than those cultured without serum. Conclusion: It is uncertain Why FCS enhanced the functional maturation of mast cells when added after week 8 of culture but suppressed mast cell development when added at day 0 of culture. Yet, the present method combining a serurn-free culture system with a serum-supplemented culture system seems to be beneficial for most of the laboratories to obtain functional human mast cells. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:137 / 143
页数:7
相关论文
共 22 条
[1]   INHIBITION OF IGE-DEPENDENT HISTAMINE-RELEASE FROM HUMAN DISPERSED LUNG MAST-CELLS BY ANTIALLERGIC DRUGS AND SALBUTAMOL [J].
CHURCH, MK ;
HIROI, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1987, 90 (02) :421-429
[2]  
CRAIG SS, 1986, AM J PATHOL, V124, P427
[3]  
CZARNETZKI BM, 1984, IMMUNOLOGY, V51, P549
[4]   LONG-TERM GENERATION OF HUMAN MAST-CELLS IN SERUM-FREE CULTURES OF CD34(+) CORD-BLOOD CELLS STIMULATED WITH STEM-CELL FACTOR AND INTERLEUKIN-3 [J].
DURAND, B ;
MIGLIACCIO, G ;
YEE, NS ;
EDDLEMAN, K ;
HUIMABYRON, T ;
MIGLIACCIO, AR ;
ADAMSON, JW .
BLOOD, 1994, 84 (11) :3667-3674
[5]   DEVELOPMENT OF HUMAN MAST-CELLS INVITRO [J].
FURITSU, T ;
SAITO, H ;
DVORAK, AM ;
SCHWARTZ, LB ;
IRANI, AMA ;
BURDICK, JF ;
ISHIZAKA, K ;
ISHIZAKA, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :10039-10043
[6]   Selective down-regulation of high-affinity IgE receptor (FcεRI) α-chain messenger RNA among transcriptome in cord blood-derived versus adult peripheral blood-derived cultured human mast cells [J].
Iida, M ;
Matsumoto, K ;
Tomita, H ;
Nakajima, T ;
Akasawa, A ;
Ohtani, NY ;
Yoshida, NL ;
Matsui, K ;
Nakada, A ;
Sugita, Y ;
Shimizu, Y ;
Wakahara, S ;
Nakao, T ;
Fujii, Y ;
Ra, C ;
Saito, H .
BLOOD, 2001, 97 (04) :1016-1022
[7]  
IRANI AMA, 1992, BLOOD, V80, P3009
[8]  
ISHIZAKA T, 1984, PROG ALLERGY, V34, P188
[9]   IL-6 attenuates apoptosis, while neither IL-6 nor IL-10 affect the numbers or protease phenotype of fetal liver-derived human mast cells [J].
Kambe, M ;
Kambe, N ;
Oskeritzian, CA ;
Schechter, N ;
Schwartz, LB .
CLINICAL AND EXPERIMENTAL ALLERGY, 2001, 31 (07) :1077-1085
[10]   An improved procedure for the development of human mast cells from dispersed fetal liver cells in serum-free culture medium [J].
Kambe, N ;
Kambe, M ;
Chang, HW ;
Matsui, A ;
Min, HK ;
Hussein, M ;
Oskerizian, CA ;
Kochan, J ;
Irani, AMA ;
Schwartz, LB .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 240 (1-2) :101-110